RadNet (RDNT) | Stock Overview & Key Data
RadNet Performance Comparison
Stock Range
Today's Range
Low: $77.62
High: $78.54
on October 2, 2025
52 Week Range
Low: $45.00
High: $93.65
on April 7, 2025
on November 11, 2024
All-Time High: $93.65 on November 11, 2024
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$6.0B
EPS
-0.19
P/E Ratio (TTM)
1,425.75
Forward P/E
99.60
P/B Ratio
6.01
PEG Ratio
-2.48
Div. Yield
N/A
ROE
1.74%
Beta
1.545
Debt to Equity
156.12
Financial Highlights
Profitability
Gross Margin
13.88%
Operating Margin
7.12%
Profit Margin
-0.78%
Returns and Earnings
Return on Assets (TTM)
1.55%
Return on Equity (TTM)
1.74%
EBITDA
$325.9M
Net Income (TTM)
$-14.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$25.77
Quarterly Revenue Growth (YoY)
8.40%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| RadNet RDNT | 5.96B Mid-cap | 4.27% | 11.41% | 40.75% | 49.17% | 11.66% | 14.07% | 312.48% | 363.49% |
| Thermo Fisher TMO | 201.36B Mega-cap | 14.32% | 7.68% | 22.72% | 7.34% | 0.46% | -12.30% | 0.26% | 12.97% |
| Danaher DHR | 136.50B Large-cap | 15.91% | 3.21% | 3.87% | 2.52% | -8.48% | -22.11% | -11.63% | 4.95% |
| Qiagen N.V QGEN | 9.69B Mid-cap | 5.26% | -1.45% | -4.93% | 15.54% | 3.86% | 6.13% | 8.77% | -15.53% |
| Guardant Health GH | 7.73B Mid-cap | 2.13% | -7.59% | 22.48% | 41.32% | 93.45% | 177.35% | 10.24% | -43.19% |
| Charles River CRL | 7.23B Mid-cap | 20.46% | 8.75% | 11.35% | 17.47% | -3.99% | -8.03% | -14.57% | -27.68% |
Ownership & Short Interest
Insider Ownership
12.67%
Institutional Ownership
94.13%
Shares Short
6M
Short Ratio
9.58
Short % of Shares Outstanding
9.88%
Average 10-Day Volume
719K
Average 90-Day Volume
663K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is RDNT's 52-week high and low?
- In the last 52 weeks, RadNet reached a high of $93.65 (on November 11, 2024) and a low of $45.00 (on April 7, 2025).
- What is the market cap and P/E ratio for RDNT?
- Curious about RadNet's size and valuation? Its market capitalization stands at 5.96B. When it comes to valuation, the P/E ratio (trailing twelve months) is 1,425.75, and the forward P/E (looking ahead) is 99.60.
- Does RDNT pay dividends? If so, what's the yield?
- As for dividends, RadNet isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are RadNet's main competitors or similar companies to consider before investing?
When looking at RadNet, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO201.36B Healthcare Diagnostics & Research -12.30% 0.26% Danaher
DHR136.50B Healthcare Diagnostics & Research -22.11% -11.63% Qiagen N.V
QGEN9.69B Healthcare Diagnostics & Research 6.13% 8.77% Guardant Health
GH7.73B Healthcare Diagnostics & Research 177.35% 10.24% Charles River
CRL7.23B Healthcare Diagnostics & Research -8.03% -14.57% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for RadNet Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of RadNet's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.74%, the Debt to Equity ratio from the most recent quarter is 156.12, and its Gross Profit Margin stands at 13.88%.
- What is the recent revenue and earnings growth for RDNT?
- Looking at RadNet's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 8.40%, and quarterly earnings saw a YoY growth of N/A.
- How much of RDNT stock is held by insiders and institutions?
- Wondering who owns RadNet stock? Company insiders (like executives and directors) hold about 12.67% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 94.13%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.